Advisory Board


Advisory Board Chairman

Giovanni Domenichini, born in Bologna in 1963, graduated in Business Administration at the University of Bologna.
He is married to Alice and has three children.

His career began at Unilever, an Anglo-Dutch multinational company, but was later called to support the family company, INVER S.p.A. a leading company in the European market for industrial coatings.
For 20 years, he was CEO of Inver, which under his leadership grew steadily up until it was sold to Valspar, a US multinational, later incorporated by Sherwin Williams Company.

Today, Giovanni Domenichini is Managing Director of the GDTRE Family Office which deals with private equity, real estate and venture capital;
Board Member of Asset Italia, the private equity fund of Tamburi Investment Partners;
Board Member of the Coveme group, a leading company in PET film processing;
and Board Member of Houdini sportswear, a Swedish company which is an international benchmark for eco-sustainable clothing.

Giovanni Domenichini is also a founding partner and member of the Board of Directors of the Rizzoli Orthopaedic Institute Foundation, one of the most important institutes in orthopaedics worldwide. Among his various tasks within the foundation, he deals with fundraising projects.

He has always practised sport at a competitive level, and firmly believes in sport as an ethical and educational value. Over time he has matured an awareness of the fundamental importance of issues such as longevity, nutrition, and sustainability, to which he dedicates time, resources, and energy in the fundamental conviction that life is the most precious gift of all.

Paola Greggio

Lucky encounters. This is how I would describe my professional career. I was born near Biella, Italy, where I was raised surrounded by wool. Biella is a center of the textile business and the “Wool Capital”, where the most high-quality woolen fabrics are produced. I started working there. My lucky encounter was with Ettore Della Giovanna and Aldo Chiappe. Both helped determine my career path. I am a journalist and have been working in the world of communication since 1980. I have worked for both international and national clients.

My strengths lie in strategic planning, creativity, and problem solving. I have managed many clients belonging to different fields, such as fashion, transport, finance, furniture, food, beverage, entertainment, etc.

I own a publishing house in Biella and for the past 43 years I have been publishing a magazine called “Made in Biella”, the novelties of local fashion machinery’s semi-finished products. We distribute the magazine at fairs such as Pitti Filati, Milano Unica, Premiere Vision, and Itma.

I love cooking and I have dedicated myself to studying Italian cuisine. I like to experiment, research stories, customs, and traditions, and also invent my own dishes. I love all aspects of the Italian “table” and the beauty of table art.

I have also developed a passion for art. In the fall, I will hold my first exhibition, featuring materic paintings that draw inspiration from my work as a communicator and press officer.

I am a widow with two children, I am Emanuele’s grandmother and I have a cat named Tom. I am Ezio’s sister, although he is much more famous than me. To know more about my passions and a bit more about my life, you can find me on Instagram as aloap 2012. I am an Aquarius.

The back of my business card reads “Generate synergies and ideas”.


Professor Valter Longo has thirty years of experience in the field of longevity, nutrition and aging to his credit and is considered one of the leading experts in the field at an international level, following in the footsteps of his mentor Roy Walford, a pioneer of studies on healthy longevity. Valter Longo is currently Professor of Biogerontology and Biological Sciences and Director of the Institute of Longevity of the School of Gerontology at the University of Southern California (USC) in Los Angeles as well as Director of the Oncology and Longevity Program at IFOM (FIRC Institute of Molecular Oncology ) in Milan. Professor Longo is the founder of the Create Cures Foundation in the United States and the Valter Longo Foundation in Italy.


Antonluca Matarazzo is a licensed attorney under the State Bar of Italy. He is a Senior International Executive with multiple years of experience in business management and development. Since 2020, he has served the Fondazione Valter Longo first as the General Director and then as Chief Executive Officer and Vice President. From 2019 to 2021 he also served as the Executive Director of the Create Cures Foundation in Los Angeles, California, USA. Professionally, he has over two decades of experience managing diverse projects and cultivating partnerships in global markets, including Africa, Europe and UAE, and in planning strategic and tactical processes, as well as directing departments and leadership teams. Prior to his relocation to the United States, he focused on cross-border businesses and transactions in the renewable energy, financial, IT and construction sectors.
Among his leadership roles, he served as a Managing Director for a European subsidiary; the CEO of a branch of an industrial group in Africa; Director of the international section of the Development Department for Europe, Africa and UAE; interim Board member of several subsidiaries; and Senior Business Manager for specific business units in Italy and Poland. He obtained his law degree in 2005 from the University of Rome “Tor Vergata”, and his MBA from “24 Ore Business School” in 2007. In addition to Italian, he is fluent in English, and French, and proficient in Spanish.


Stefano is a serial entrepreneur and former professor of information systems, network services and security. He is the founder of I.NET, the first Italian internet provider, and played an important role in the making of the Italian internet system. He was a member of the Italian Parliament in the XVII legislature, member of the Commission for Internet rights in the House of Representatives, and leader of Parliament’s Intergroup for technological innovation. Stefano is a member of the scientific committee at Bollati and Boringhieri and the Leonardo Foundation, as well as a contributor to the Pontifical Academy of Sciences, President of the Italian Digital Agency Steering Committee, member of the Artificial Intelligence group of the European Commission, and a member of the leadership board of the UN-Sustainable Development Solutions Network. Additionally, he is the author of numerous articles and contributions, speaker at conferences on digital technology, regulation and competition; which stems from his interest in the intersectionality between technology, regulation, and markets.


Born in Losanna, Sweden on January 25th 1953, he is a descendant of the Agnelli family. The 5th child of Susanna Agnelli and Urbano Rattazzi. Since 2004, he has been the president at Neos flying company, a member of the Board of Directors of Exor, and the holding company of the Agnellis; and since 2001, president of the Italian Hospital Group, as well as the managing director of GL investments. He also founded a civic committee in Rome. He studied Economics at Columbia University, and then completed a master’s degree at Harvard University. Additionally, he worked at Lehman and Salomon, and was later pioneer of private European airlines and founded Air Europe. As well as president of Assaereo, Association of italian airlines,and member of Confindustria. Among other positions, from 1988 to 200 he was founder and president of Air Europe; from 2003-2018 a board member of EXOR NV (previously EXOR SpA and IFI SpA); and from 2005 to 2012 Vice President of Alpitour. Furthermore, he holds the following institutional positions: Board member of Finnat Euramerica Bank (since 2009); President of the Il Faro Foundation (since 2009); Board member of Coe and Clerici (since 2015) and Coe and Clerici Vianini Spa (since 2015), and a Board member of the Telethon Foundation (since 2015).


Join our Newsletter to stay updated with the Foundation projects and new advances in diseases prevention and treatment.